SANJAY SINGH: Open Payments
NPI 1952403362 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 40 payments from 6 companies in 2025. Trend: 2023 $612 · 2024 $713 · 2025 $708
Food & beverage: $708
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $215 |
| Otsuka America Pharmaceutical, Inc. | 11 | $184 |
| Janssen Pharmaceuticals, Inc | 7 | $140 |
| Lundbeck LLC | 4 | $83 |
| Alkermes, Inc. | 3 | $51 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
Products named: UZEDY, ABILIFY MAINTENA, INVEGA SUSTENNA, ARISTADA, INGREZZA, ABILIFY ASIMTUFII, REXULTI.
Industry payments across AL — which companies pay providers there.
